HopeStage
Back to overview

ADHD studies

Topics
More filters

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 841-852 of 1,811
Device study icon
CompletedNCT03888391

12 Month Open Extension of TNS for ADHD.

Official study title

12 Month Open Extension Study of TNS for ADHD .

This study has finished and is no longer accepting participants.

In Los Angeles
ADHDDevice studyAges 8–13
Countries
United States
Sponsor
James McGough
Drug study icon
CompletedNCT00326300

Safety study of Methylphenidate HCL Tablets at Multiple Dose Levels in ADHD

Official study title

An Open-Label, Dose-Titration, Long-Term Safety Study to Evaluate CONCERTA (Methylphenidate HCL) Extended-release Tablets at Doses of 36 mg, 54 mg, 72 mg, 90 mg, and 108 mg Per Day in Adults With Attention Deficit Hyperactivity Disorder

This study has finished and is no longer accepting participants.

Location not clearly listed
ADHDMedication studyAges 18–65
Countries
Sponsor
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.